πŸ‡ΊπŸ‡Έ FDA
Patent

US 6372250

Non-invasive gene targeting to the brain

expired A61KA61K47/6913A61K48/00

Quick answer

US patent 6372250 (Non-invasive gene targeting to the brain) held by The Regents of the University of California expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K47/6913, A61K48/00, A61K48/0041, A61K9/0019